Abstract
AbstractSince the 1960s, homoeopaths, along with biomedical physicians, have generally acknowledged the double-blind, randomized, controlled trial (RCT) as the ‘gold standard’ for establishing the efficacy of a clinical intervention. The homoeopathic profession has, however, been ambivalent about the incorporation of the RCT model for the internal validation of homoeopathic medicines. This paper looks at important components of the RCT such as blind assessment, randomization and statistical inference and examines some of the historical and scientific issues about their adoption for homoeopathic provings.
Subject
Complementary and alternative medicine,Pharmacology
Reference68 articles.
1. Complementary medicine—efficacy beyond the placebo effect;Kaptchuk,1996
2. Professional organisation and the development of medical knowledge: two interpretations of homoeopathy;Rankin,1988
3. Report on a proving of Pulsatilla 3x;Clover;Br Hom J,1980
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献